Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular water protons are the hydrogen nuclei (1H) found within water molecules in the interstitial and intravascular compartments of the body (Grover et al., 2015). In clinical pharmacology and radiology, these protons act as the primary physical target for Magnetic Resonance Imaging (MRI) contrast agents, which are designed to alter the magnetic properties of the local water environment (Idée et al., 2006). Paramagnetic agents, such as gadolinium-based contrast media (GBCAs), interact with these protons via dipole-dipole interactions to shorten their longitudinal (T1) and transverse (T2) relaxation times (Aime & Caravan, 2009). This process enhances the signal intensity on MRI scans, allowing for the high-contrast visualization of physiological and pathological processes (Wahsner et al., 2019). Specifically, changes in the distribution and relaxation behavior of extracellular water protons are used to assess vascular permeability, tissue perfusion, and the presence of lesions in diseases such as cancer, multiple sclerosis, and myocardial infarction (Caravan et al., 1999). While not a traditional protein receptor, the manipulation of these protons is fundamental to modern diagnostic imaging and the monitoring of therapeutic efficacy in various clinical settings (Kanda et al., 2014).
Paramagnetic or superparamagnetic modulation of longitudinal (T1) and transverse (T2) relaxation rates of water protons through dipole-dipole interactions and inner-sphere/outer-sphere coordination (Aime & Caravan, 2009).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular water protons (H+).